Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Adagio Medical Reports $17.8 Million Third-Quarter Net Income

None

Adagio Medical Holdings Inc. (ADGM) reported third-quarter 2026 net income of $17.8 million, compared with a net loss of $10.1 million a year earlier. Revenue was zero in both periods.

The company said third-quarter net income was primarily driven by a $23.0 million noncash gain from the change in fair value of its 13% Senior Secured Convertible Notes. Adagio also said its board is continuing a formal review of strategic alternatives.

  • Basic net income per share was $2.40, while diluted net loss per share was $5.13.
  • Research and development expense was $1.8 million, down from $2.8 million a year earlier.
  • Selling, general and administrative expense was $2.6 million, compared with $2.9 million.
  • Cash and cash equivalents totaled $3.1 million as of September 30, 2026.
  • The company treated 22 patients with its vCLAS Ultra System in the U.S. and Canada during the period.
EARLY ACCESS
Receive ADGM Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

$ADGM Hedge Fund Activity

We have seen 8 institutional investors add shares of $ADGM stock to their portfolio, and 11 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles